EA201990295A1 - THERAPEUTIC COMPOUNDS THAT CAN BE USED FOR PREVENTIVE OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION - Google Patents

THERAPEUTIC COMPOUNDS THAT CAN BE USED FOR PREVENTIVE OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION

Info

Publication number
EA201990295A1
EA201990295A1 EA201990295A EA201990295A EA201990295A1 EA 201990295 A1 EA201990295 A1 EA 201990295A1 EA 201990295 A EA201990295 A EA 201990295A EA 201990295 A EA201990295 A EA 201990295A EA 201990295 A1 EA201990295 A1 EA 201990295A1
Authority
EA
Eurasian Patent Office
Prior art keywords
therapeutic
preventive
hiv virus
virus infection
compounds
Prior art date
Application number
EA201990295A
Other languages
Russian (ru)
Other versions
EA036921B1 (en
Inventor
Майкл Грауп
Стивен Дж. Генри
Джон О. Линк
Чарльз Уильям Роу
Роланд Д. Сайто
Скотт Д. Шрёдер
Димитриос Стефанидис
Уинстон С. Це
Дженнифер Р. Чжан
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Priority claimed from PCT/US2017/047416 external-priority patent/WO2018035359A1/en
Publication of EA201990295A1 publication Critical patent/EA201990295A1/en
Publication of EA036921B1 publication Critical patent/EA036921B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/08—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее описание относится к соединениям формул (Ia), (Ib), (IIa) и (IIb):которые можно применять в лечении инфекций, вызываемых вирусами Retroviridae, включая инфекции, вызываемые вирусом ВИЧ.The present description relates to compounds of formulas (Ia), (Ib), (IIa) and (IIb): which can be used in the treatment of infections caused by Retroviridae viruses, including infections caused by the HIV virus.

EA201990295A 2017-02-10 2017-08-17 Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection EA036921B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762457555P 2017-02-10 2017-02-10
PCT/US2017/047416 WO2018035359A1 (en) 2016-08-19 2017-08-17 Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection

Publications (2)

Publication Number Publication Date
EA201990295A1 true EA201990295A1 (en) 2019-07-31
EA036921B1 EA036921B1 (en) 2021-01-15

Family

ID=67399624

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990295A EA036921B1 (en) 2017-02-10 2017-08-17 Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection

Country Status (1)

Country Link
EA (1) EA036921B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI706945B (en) * 2013-03-01 2020-10-11 美商基利科學股份有限公司 Therapeutic compounds for treating a retroviridae viral infection
CA2971640C (en) * 2015-07-06 2020-09-22 Gilead Sciences, Inc. Cot modulators and methods of use thereof

Also Published As

Publication number Publication date
EA036921B1 (en) 2021-01-15

Similar Documents

Publication Publication Date Title
PH12019500335A1 (en) Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
EA202091114A1 (en) NEW HIGHLY ACTIVE PYRAZOLOPIPERIDINE-SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
EA201890735A1 (en) Modulators of the cow protein of the hepatitis B virus
EA202091113A1 (en) NEW HIGHLY ACTIVE AMINOTHIAZOL SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
EA201791515A1 (en) COMPOUNDS OF PYRAZINE FOR THE TREATMENT OF INFECTIOUS DISEASES
MD3294738T2 (en) Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
EA201792069A1 (en) DERIVATIVES OF AZOKANES AND AZONAS AND METHODS OF TREATING INFECTIONS OF HEPATITIS B
EA201992784A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201992329A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201690687A1 (en) REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
EA201992334A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201791614A1 (en) INDOL DERIVATIVES AS AN INHIBITORS OF DENGE VIRUS REPLICATION
EA201890722A1 (en) Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication
EA201692358A1 (en) IZOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTION
EA202091849A1 (en) THIAZOLIDE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS
PH12019500513A1 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
MX2019004029A (en) Compounds and methods for diagnosis and treatment of viral infections.
MX2021001612A (en) Compounds useful in hiv therapy.
EA201690594A1 (en) COMPOSITION FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ATAZANAVIR AND COBICISTAT
EA201790776A1 (en) COMBINED COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS OF TREATING HEPATITIS C